Indeed, due to inhibitory effects on cell growth, TXNIP is classified as a tumor suppressor [42, 47], and downregulation of TXNIP expression in a variety of human cancers, including B cell lymphoma, has been reported [66–68]. The gene discussed is TXNIP; the disease is cancer.